サマリー

トラマドール（INN）は、非オピオイド系の中枢性鎮痛薬で、オピオイド受容体にも結合できるが、その親和性は弱く、相対的な受容体への親和性はモルヒネの1/6000に相当し、and受容体への親和性は1/25に過ぎない。本剤は合成薬であり、s-オピオイド受容体のほか、ノルエピネフリン系やセロトニン系にも作用する。

市場分析と洞察。トラマドール（INN）の世界市場
Tramadol (INN)の世界市場規模は、2020年のXX百万米ドルから、2021-2027年の間にXX％のCAGRで、2027年にはXX百万米ドルに達すると予測されます。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界のTramadol（INN）市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つよう、見事な試みを行っています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができ、その中には、収益面での世界のトラマドール（INN）市場全体のサイズも含まれています。
本レポートは、世界のTramadol(INN)市場において競合他社よりも優位に立ち、永続的な成功を収めるための効果的なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界のTramadol (INN)市場を詳細に調査するために、独自の業界最高水準の調査・分析手法を用いています。

世界のトラマドール（INN）の範囲と市場規模
トラマドール（INN）市場は、企業別、地域（国）別、タイプ別、用途別に分類されています。世界のTramadol (INN)市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間における、タイプ別、アプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
規格別
カプセル
注射剤
坐薬
リリーバー
薬物送達方法別
静脈注射
筋肉内注射
皮下注射
経口
薬のための肛門

用途別セグメント
疼痛緩和
癌性疼痛緩和
陣痛の緩和
風邪の症状緩和
咳の緩和

地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
CSL社
グレンタール社
Mundipharma
ヘキサルAG
ラボファム
プリバファーマ
日本新薬
アトズ製薬
ロムファーム社
アムネール製薬
パー製薬
コーシャ製薬
CSPC
新華製薬
ティエンロン シーアイ
メドケミー
湖北銭江製薬
紫耀グループ
晨晨（しんしん）製薬
西南製薬
山東新華製薬
上海合肥製薬
デュオデュオ製薬
eicare製薬
貴州易康製薬

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tramadol (INN) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Capsule
1.2.3 Injection
1.2.4 Suppositories
1.2.5 Relievers
1.3 Market by Application
1.3.1 Global Tramadol (INN) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pain Relief
1.3.3 Cancer Pain Relief
1.3.4 Labor Pain
1.3.5 Cold Relief
1.3.6 Cough Relief
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Tramadol (INN) Market Perspective (2016-2027)
2.2 Tramadol (INN) Growth Trends by Regions
2.2.1 Tramadol (INN) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Tramadol (INN) Historic Market Share by Regions (2016-2021)
2.2.3 Tramadol (INN) Forecasted Market Size by Regions (2022-2027)
2.3 Tramadol (INN) Industry Dynamic
2.3.1 Tramadol (INN) Market Trends
2.3.2 Tramadol (INN) Market Drivers
2.3.3 Tramadol (INN) Market Challenges
2.3.4 Tramadol (INN) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Tramadol (INN) Players by Revenue
3.1.1 Global Top Tramadol (INN) Players by Revenue (2016-2021)
3.1.2 Global Tramadol (INN) Revenue Market Share by Players (2016-2021)
3.2 Global Tramadol (INN) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tramadol (INN) Revenue
3.4 Global Tramadol (INN) Market Concentration Ratio
3.4.1 Global Tramadol (INN) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tramadol (INN) Revenue in 2020
3.5 Tramadol (INN) Key Players Head office and Area Served
3.6 Key Players Tramadol (INN) Product Solution and Service
3.7 Date of Enter into Tramadol (INN) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Tramadol (INN) Breakdown Data by Type
4.1 Global Tramadol (INN) Historic Market Size by Type (2016-2021)
4.2 Global Tramadol (INN) Forecasted Market Size by Type (2022-2027)

5 Tramadol (INN) Breakdown Data by Application
5.1 Global Tramadol (INN) Historic Market Size by Application (2016-2021)
5.2 Global Tramadol (INN) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Tramadol (INN) Market Size (2016-2027)
6.2 North America Tramadol (INN) Market Size by Type
6.2.1 North America Tramadol (INN) Market Size by Type (2016-2021)
6.2.2 North America Tramadol (INN) Market Size by Type (2022-2027)
6.2.3 North America Tramadol (INN) Market Size by Type (2016-2027)
6.3 North America Tramadol (INN) Market Size by Application
6.3.1 North America Tramadol (INN) Market Size by Application (2016-2021)
6.3.2 North America Tramadol (INN) Market Size by Application (2022-2027)
6.3.3 North America Tramadol (INN) Market Size by Application (2016-2027)
6.4 North America Tramadol (INN) Market Size by Country
6.4.1 North America Tramadol (INN) Market Size by Country (2016-2021)
6.4.2 North America Tramadol (INN) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Tramadol (INN) Market Size (2016-2027)
7.2 Europe Tramadol (INN) Market Size by Type
7.2.1 Europe Tramadol (INN) Market Size by Type (2016-2021)
7.2.2 Europe Tramadol (INN) Market Size by Type (2022-2027)
7.2.3 Europe Tramadol (INN) Market Size by Type (2016-2027)
7.3 Europe Tramadol (INN) Market Size by Application
7.3.1 Europe Tramadol (INN) Market Size by Application (2016-2021)
7.3.2 Europe Tramadol (INN) Market Size by Application (2022-2027)
7.3.3 Europe Tramadol (INN) Market Size by Application (2016-2027)
7.4 Europe Tramadol (INN) Market Size by Country
7.4.1 Europe Tramadol (INN) Market Size by Country (2016-2021)
7.4.2 Europe Tramadol (INN) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Tramadol (INN) Market Size (2016-2027)
8.2 Asia-Pacific Tramadol (INN) Market Size by Type
8.2.1 Asia-Pacific Tramadol (INN) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Tramadol (INN) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Tramadol (INN) Market Size by Type (2016-2027)
8.3 Asia-Pacific Tramadol (INN) Market Size by Application
8.3.1 Asia-Pacific Tramadol (INN) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Tramadol (INN) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Tramadol (INN) Market Size by Application (2016-2027)
8.4 Asia-Pacific Tramadol (INN) Market Size by Region
8.4.1 Asia-Pacific Tramadol (INN) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Tramadol (INN) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Tramadol (INN) Market Size (2016-2027)
9.2 Latin America Tramadol (INN) Market Size by Type
9.2.1 Latin America Tramadol (INN) Market Size by Type (2016-2021)
9.2.2 Latin America Tramadol (INN) Market Size by Type (2022-2027)
9.2.3 Latin America Tramadol (INN) Market Size by Type (2016-2027)
9.3 Latin America Tramadol (INN) Market Size by Application
9.3.1 Latin America Tramadol (INN) Market Size by Application (2016-2021)
9.3.2 Latin America Tramadol (INN) Market Size by Application (2022-2027)
9.3.3 Latin America Tramadol (INN) Market Size by Application (2016-2027)
9.4 Latin America Tramadol (INN) Market Size by Country
9.4.1 Latin America Tramadol (INN) Market Size by Country (2016-2021)
9.4.2 Latin America Tramadol (INN) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Tramadol (INN) Market Size (2016-2027)
10.2 Middle East & Africa Tramadol (INN) Market Size by Type
10.2.1 Middle East & Africa Tramadol (INN) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Tramadol (INN) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Tramadol (INN) Market Size by Type (2016-2027)
10.3 Middle East & Africa Tramadol (INN) Market Size by Application
10.3.1 Middle East & Africa Tramadol (INN) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Tramadol (INN) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Tramadol (INN) Market Size by Application (2016-2027)
10.4 Middle East & Africa Tramadol (INN) Market Size by Country
10.4.1 Middle East & Africa Tramadol (INN) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Tramadol (INN) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 CSL Limited
11.1.1 CSL Limited Company Details
11.1.2 CSL Limited Business Overview
11.1.3 CSL Limited Tramadol (INN) Introduction
11.1.4 CSL Limited Revenue in Tramadol (INN) Business (2016-2021)
11.1.5 CSL Limited Recent Development
11.2 Grnenthal GmbH
11.2.1 Grnenthal GmbH Company Details
11.2.2 Grnenthal GmbH Business Overview
11.2.3 Grnenthal GmbH Tramadol (INN) Introduction
11.2.4 Grnenthal GmbH Revenue in Tramadol (INN) Business (2016-2021)
11.2.5 Grnenthal GmbH Recent Development
11.3 Mundipharma
11.3.1 Mundipharma Company Details
11.3.2 Mundipharma Business Overview
11.3.3 Mundipharma Tramadol (INN) Introduction
11.3.4 Mundipharma Revenue in Tramadol (INN) Business (2016-2021)
11.3.5 Mundipharma Recent Development
11.4 Hexal AG
11.4.1 Hexal AG Company Details
11.4.2 Hexal AG Business Overview
11.4.3 Hexal AG Tramadol (INN) Introduction
11.4.4 Hexal AG Revenue in Tramadol (INN) Business (2016-2021)
11.4.5 Hexal AG Recent Development
11.5 Labopharm
11.5.1 Labopharm Company Details
11.5.2 Labopharm Business Overview
11.5.3 Labopharm Tramadol (INN) Introduction
11.5.4 Labopharm Revenue in Tramadol (INN) Business (2016-2021)
11.5.5 Labopharm Recent Development
11.6 Pliva Pharma
11.6.1 Pliva Pharma Company Details
11.6.2 Pliva Pharma Business Overview
11.6.3 Pliva Pharma Tramadol (INN) Introduction
11.6.4 Pliva Pharma Revenue in Tramadol (INN) Business (2016-2021)
11.6.5 Pliva Pharma Recent Development
11.7 Nippon Shinyaku
11.7.1 Nippon Shinyaku Company Details
11.7.2 Nippon Shinyaku Business Overview
11.7.3 Nippon Shinyaku Tramadol (INN) Introduction
11.7.4 Nippon Shinyaku Revenue in Tramadol (INN) Business (2016-2021)
11.7.5 Nippon Shinyaku Recent Development
11.8 Atoz Pharmaceuticals
11.8.1 Atoz Pharmaceuticals Company Details
11.8.2 Atoz Pharmaceuticals Business Overview
11.8.3 Atoz Pharmaceuticals Tramadol (INN) Introduction
11.8.4 Atoz Pharmaceuticals Revenue in Tramadol (INN) Business (2016-2021)
11.8.5 Atoz Pharmaceuticals Recent Development
11.9 Rompharm Company
11.9.1 Rompharm Company Company Details
11.9.2 Rompharm Company Business Overview
11.9.3 Rompharm Company Tramadol (INN) Introduction
11.9.4 Rompharm Company Revenue in Tramadol (INN) Business (2016-2021)
11.9.5 Rompharm Company Recent Development
11.10 Amneal Pharmaceuticals
11.10.1 Amneal Pharmaceuticals Company Details
11.10.2 Amneal Pharmaceuticals Business Overview
11.10.3 Amneal Pharmaceuticals Tramadol (INN) Introduction
11.10.4 Amneal Pharmaceuticals Revenue in Tramadol (INN) Business (2016-2021)
11.10.5 Amneal Pharmaceuticals Recent Development
11.11 Par Pharmaceutical
11.11.1 Par Pharmaceutical Company Details
11.11.2 Par Pharmaceutical Business Overview
11.11.3 Par Pharmaceutical Tramadol (INN) Introduction
11.11.4 Par Pharmaceutical Revenue in Tramadol (INN) Business (2016-2021)
11.11.5 Par Pharmaceutical Recent Development
11.12 Kosher Pharmaceuticals
11.12.1 Kosher Pharmaceuticals Company Details
11.12.2 Kosher Pharmaceuticals Business Overview
11.12.3 Kosher Pharmaceuticals Tramadol (INN) Introduction
11.12.4 Kosher Pharmaceuticals Revenue in Tramadol (INN) Business (2016-2021)
11.12.5 Kosher Pharmaceuticals Recent Development
11.13 CSPC
11.13.1 CSPC Company Details
11.13.2 CSPC Business Overview
11.13.3 CSPC Tramadol (INN) Introduction
11.13.4 CSPC Revenue in Tramadol (INN) Business (2016-2021)
11.13.5 CSPC Recent Development
11.14 Xinhua Pharmaceutical
11.14.1 Xinhua Pharmaceutical Company Details
11.14.2 Xinhua Pharmaceutical Business Overview
11.14.3 Xinhua Pharmaceutical Tramadol (INN) Introduction
11.14.4 Xinhua Pharmaceutical Revenue in Tramadol (INN) Business (2016-2021)
11.14.5 Xinhua Pharmaceutical Recent Development
11.15 Tianlong Shiye
11.15.1 Tianlong Shiye Company Details
11.15.2 Tianlong Shiye Business Overview
11.15.3 Tianlong Shiye Tramadol (INN) Introduction
11.15.4 Tianlong Shiye Revenue in Tramadol (INN) Business (2016-2021)
11.15.5 Tianlong Shiye Recent Development
11.16 Medochemie
11.16.1 Medochemie Company Details
11.16.2 Medochemie Business Overview
11.16.3 Medochemie Tramadol (INN) Introduction
11.16.4 Medochemie Revenue in Tramadol (INN) Business (2016-2021)
11.16.5 Medochemie Recent Development
11.17 Hubei Qianjiang Pharmaceutical
11.17.1 Hubei Qianjiang Pharmaceutical Company Details
11.17.2 Hubei Qianjiang Pharmaceutical Business Overview
11.17.3 Hubei Qianjiang Pharmaceutical Tramadol (INN) Introduction
11.17.4 Hubei Qianjiang Pharmaceutical Revenue in Tramadol (INN) Business (2016-2021)
11.17.5 Hubei Qianjiang Pharmaceutical Recent Development
11.18 Shiyao Group
11.18.1 Shiyao Group Company Details
11.18.2 Shiyao Group Business Overview
11.18.3 Shiyao Group Tramadol (INN) Introduction
11.18.4 Shiyao Group Revenue in Tramadol (INN) Business (2016-2021)
11.18.5 Shiyao Group Recent Development
11.18 Chenxin Pharmaceutical
11.25.1 Chenxin Pharmaceutical Company Details
11.25.2 Chenxin Pharmaceutical Business Overview
11.25.3 Chenxin Pharmaceutical Tramadol (INN) Introduction
11.25.4 Chenxin Pharmaceutical Revenue in Tramadol (INN) Business (2016-2021)
11.25.5 Chenxin Pharmaceutical Recent Development
11.20 Southwest Pharmaceutical
11.20.1 Southwest Pharmaceutical Company Details
11.20.2 Southwest Pharmaceutical Business Overview
11.20.3 Southwest Pharmaceutical Tramadol (INN) Introduction
11.20.4 Southwest Pharmaceutical Revenue in Tramadol (INN) Business (2016-2021)
11.20.5 Southwest Pharmaceutical Recent Development
11.21 Shandong Xinhua Pharmaceutical
11.21.1 Shandong Xinhua Pharmaceutical Company Details
11.21.2 Shandong Xinhua Pharmaceutical Business Overview
11.21.3 Shandong Xinhua Pharmaceutical Tramadol (INN) Introduction
11.21.4 Shandong Xinhua Pharmaceutical Revenue in Tramadol (INN) Business (2016-2021)
11.21.5 Shandong Xinhua Pharmaceutical Recent Development
11.22 Shanghai Hefeng Pharmaceutical
11.22.1 Shanghai Hefeng Pharmaceutical Company Details
11.22.2 Shanghai Hefeng Pharmaceutical Business Overview
11.22.3 Shanghai Hefeng Pharmaceutical Tramadol (INN) Introduction
11.22.4 Shanghai Hefeng Pharmaceutical Revenue in Tramadol (INN) Business (2016-2021)
11.22.5 Shanghai Hefeng Pharmaceutical Recent Development
11.23 Duoduo Pharmaceutical
11.23.1 Duoduo Pharmaceutical Company Details
11.23.2 Duoduo Pharmaceutical Business Overview
11.23.3 Duoduo Pharmaceutical Tramadol (INN) Introduction
11.23.4 Duoduo Pharmaceutical Revenue in Tramadol (INN) Business (2016-2021)
11.23.5 Duoduo Pharmaceutical Recent Development
11.24 EICARE PHARMACEUTICAL
11.24.1 EICARE PHARMACEUTICAL Company Details
11.24.2 EICARE PHARMACEUTICAL Business Overview
11.24.3 EICARE PHARMACEUTICAL Tramadol (INN) Introduction
11.24.4 EICARE PHARMACEUTICAL Revenue in Tramadol (INN) Business (2016-2021)
11.24.5 EICARE PHARMACEUTICAL Recent Development
11.25 Guizhou Yikang Pharmaceutical
11.25.1 Guizhou Yikang Pharmaceutical Company Details
11.25.2 Guizhou Yikang Pharmaceutical Business Overview
11.25.3 Guizhou Yikang Pharmaceutical Tramadol (INN) Introduction
11.25.4 Guizhou Yikang Pharmaceutical Revenue in Tramadol (INN) Business (2016-2021)
11.25.5 Guizhou Yikang Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details